188 related articles for article (PubMed ID: 1277129)
1. Correlation of antitumor chemoimmunotherapy with bone marrow macrophage precursor cell stimulation and macrophage cytotoxicity.
Fisher B; Wolmark N
Cancer Res; 1976 Jul; 36(7 PT 1):2241-7. PubMed ID: 1277129
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
Fisher B; Gebhardt M
Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
[TBL] [Abstract][Full Text] [Related]
3. The effect of a growing tumor and its removal on the cytotoxicity of macrophages from cultured bone marrow cells.
Fisher B; Wolmark N; Coyle J; Saffer EA
Cancer Res; 1976 Jul; 36(7 PT 1):2302-5. PubMed ID: 1277133
[TBL] [Abstract][Full Text] [Related]
4. In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.
Schlick E; Ruffmann R; Chirigos MA; Welker RD; Herberman RB
Cancer Res; 1985 Mar; 45(3):1108-14. PubMed ID: 3871661
[TBL] [Abstract][Full Text] [Related]
5. The effect of bone marrow depletion on prostaglandin E-producing suppressor macrophages in mouse spleen.
Shibata Y; Volkman A
J Immunol; 1985 Dec; 135(6):3897-904. PubMed ID: 2933455
[TBL] [Abstract][Full Text] [Related]
6. Effects of cyclophosphamide on murine bone marrow and splenic megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels.
Yeager AM; Levin FC; Levin J
J Cell Physiol; 1982 Aug; 112(2):222-8. PubMed ID: 7119022
[TBL] [Abstract][Full Text] [Related]
7. Further observations on the effect of cyclophosphamide on intratumor and peripheral leukocyte levels.
Evans R
Am J Pathol; 1980 Jun; 99(3):667-84. PubMed ID: 7386598
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.
van Os R; Robinson S; Sheridan T; Mauch PM
Stem Cells; 2000; 18(2):120-7. PubMed ID: 10742384
[TBL] [Abstract][Full Text] [Related]
9. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant murine granulocyte-macrophage colony-stimulating factor in cyclophosphamide-treated mice.
Gamba-Vitalo C; DiGiovanna MP; Sartorelli AC
Blood Cells; 1991; 17(1):193-205; discussion 206-8. PubMed ID: 2018856
[TBL] [Abstract][Full Text] [Related]
11. Further observations on the inhibition of tumor growth by corynebacterium parvum with cyclophosphamide.
Fisher B; Rubin H; Wolmark N
J Natl Cancer Inst; 1976 Aug; 57(2):317-22. PubMed ID: 1003514
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid.
Youn JK; Lacour F; Hue G
Cancer Res; 1982 Nov; 42(11):4706-11. PubMed ID: 7127305
[TBL] [Abstract][Full Text] [Related]
13. The influence of cyclophosphamide on antibody formation in the mouse.
Willers JM; Sluis E
Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
[TBL] [Abstract][Full Text] [Related]
14. The effects of 5-fluorouracil on hematopoiesis: studies of murine megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels.
Yeager AM; Levin J; Levin FC
Exp Hematol; 1983 Nov; 11(10):944-52. PubMed ID: 6662215
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle status of murine megakaryocyte and granulocyte-macrophage colony-forming cells in bone marrow and spleen.
Cen D; Levin J
Exp Hematol; 1992 Oct; 20(9):1094-100. PubMed ID: 1468543
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
[TBL] [Abstract][Full Text] [Related]
17. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
[TBL] [Abstract][Full Text] [Related]
18. The effect of hemopoietic microenvironment on splenic suppressor macrophages in congenitally anemic mice of genotype Sl/Sld.
Shibata Y; Volkman A
J Immunol; 1985 Dec; 135(6):3905-10. PubMed ID: 4067308
[TBL] [Abstract][Full Text] [Related]
19. Effect of the in vivo priming regimen for peripheral blood stem cells (PBSC) mobilization on in vitro generation of cytotoxic effectors by IL-2 activation of PBSC in a murine model.
Verma UN; Yankelevich B; Hodgson J; Mazumder A
Bone Marrow Transplant; 1997 Feb; 19(3):265-73. PubMed ID: 9028557
[TBL] [Abstract][Full Text] [Related]
20. Diethyldithiocarbamate inhibition of murine bone marrow toxicity caused by cis-diamminedichloroplatinum(II) or diammine-(1,1-cyclobutanedicarboxylato)platinum(II).
Gringeri A; Keng PC; Borch RF
Cancer Res; 1988 Oct; 48(20):5708-12. PubMed ID: 2844391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
